D. E. Shaw & Co., Inc. Mirati Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $5.54 Million - $8.23 Million	-131,920 Reduced 94.49%	7,693 $451,000
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $3.43 Million - $5.59 Million	-123,325 Reduced 46.9%	139,613 $6.08 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $626,927 - $858,750	17,352 Added 7.07%	262,938 $9.5 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $1.18 Million - $1.75 Million	32,285 Added 15.14%	245,586 $9.13 Million
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $14.6 Million - $34.8 Million	-353,129 Reduced 62.34%	213,301 $9.66 Million

Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $14.8 Million - $21.6 Million	249,522 Added 78.74%	566,430 $39.6 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $12.4 Million - $28.1 Million	316,908 New	316,908 $21.3 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $205,927 - $410,034	-2,716 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $1.27 Million - $1.83 Million	-9,592 Reduced 77.93%	2,716 $398,000
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $13.9 Million - $18.7 Million	-105,339 Reduced 89.54%	12,308 $2.18 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $5.14 Million - $6.42 Million	35,725 Added 43.61%	117,647 $19 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $2.97 Million - $4.14 Million	18,660 Added 29.5%	81,922 $14 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $4.52 Million - $6.7 Million	27,897 Added 78.88%	63,262 $13.9 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $3.58 Million - $5.29 Million	31,602 Added 839.81%	35,365 $5.87 Million
Q1 2019 May 15, 2019	SELL	$43.65 - $78.95 $543,966 - $983,874	-12,462 Reduced 76.81%	3,763 $276,000
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $1.39 Million - $2.06 Million	-43,520 Reduced 72.84%	16,225 $688,000
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $6.86 Million - $9.13 Million	-145,601 Reduced 70.91%	59,745 $2.81 Million
Q2 2018 Aug 14, 2018	SELL	$26.05 - $52.4 $2.05 Million - $4.13 Million	-78,745 Reduced 27.72%	205,346 $10.1 Million
Q1 2018 May 15, 2018	SELL	$17.2 - $34.95 $3.34 Million - $6.79 Million	-194,392 Reduced 40.63%	284,091 $8.72 Million
Q4 2017 Feb 14, 2018	SELL	$12.65 - $19.0 $1.25 Million - $1.87 Million	-98,599 Reduced 17.09%	478,483 $8.73 Million
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $2.71 Million - $6.75 Million	577,082	577,082 $6.75 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account